Carrera Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Carrera Capital Advisors's LLY Position: Q3 2026 in Review
Carrera Capital Advisors increased its Eli Lilly (LLY) stake by 174% in Q3 2026, buying an estimated $2.07M and bringing the position to 2,764 shares worth $3.2M. The position accounts for 0.45% of the portfolio, ranked #49.
Carrera Capital Advisors first reported a position in LLY in Q3 2024 and has held it in 9 quarters since. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Carrera Capital Advisors held 2,764 shares of Eli Lilly worth $3.2M as of Q3 2026.
- Carrera Capital Advisors bought 1,757 Eli Lilly shares in Q3 2026, an estimated $2.07M.
- Eli Lilly made up 0.45% of Carrera Capital Advisors's portfolio in Q3 2026, its #49 holding.
- Carrera Capital Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 9 quarters since.
- 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Carrera Capital Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.